title: Enhancing Skin Permeation of Biphenylacetic Acid (BPA) Using Salt Formation with Organic and Alkali Metal Bases.
abstract: In the present study, a series of organic and alkali metal salts of biphenylacetic acid (BPA) have been prepared and evaluated in vitro for percutaneous drug delivery. The physicochemical properties of BPA salts were determined using solubility measurements, DSC, and IR. The DSC thermogram and FTIR spectra confirmed the salt formation with organic and alkali metal bases. Among the series, salts with organic amines (ethanolamine, diethanolamine, triethanolamine, and diethylamine) had lowered melting points while the alkali metal salt (sodium) had a higher melting point than BPA. The in vitro study showed that salt formation improves the physicochemical properties of BPA, leading to improved permeability through the skin. Amongst all the prepared salts, ethanolamine salt (1b) showed 7.2- and 5.4-fold higher skin permeation than the parent drug at pH 7.4 and 5.0, respectively, using rat skin.
authors.affiliation: Pharmacy Department, Faculty of Technology & Engineering, The M. S. University of Baroda, Vadodara-390001, India.
authors.forename: Vijay
authors.initials: V
authors.lastname: Pawar
authors.affiliation: Pharmacy Department, Faculty of Technology & Engineering, The M. S. University of Baroda, Vadodara-390001, India.
authors.forename: Prashant
authors.initials: P
authors.lastname: Naik
authors.affiliation: Pharmacy Department, Faculty of Technology & Engineering, The M. S. University of Baroda, Vadodara-390001, India.
authors.forename: Rajani
authors.initials: R
authors.lastname: Giridhar
authors.affiliation: Pharmacy Department, Faculty of Technology & Engineering, The M. S. University of Baroda, Vadodara-390001, India.
authors.forename: Mange Ram
authors.initials: MR
authors.lastname: Yadav
keywords: BPA; Lipophilicity; NSAID; Salt; Skin permeation
references.citation: Eur J Clin Pharmacol. 1994;47(4):297-303
references.pmid: 7875178
references.citation: Pharm Dev Technol. 2012 Jan-Feb;17(1):48-54
references.pmid: 20858066
references.citation: Pharm Res. 2002 Sep;19(9):1375-80
references.pmid: 12403076
references.citation: Inflammopharmacology. 1999;7(4):339-50
references.pmid: 17657437
references.citation: J Pharm Sci. 2004 Jan;93(1):144-54
references.pmid: 14648644
references.citation: Eur J Pharm Sci. 2012 Dec 18;47(5):890-5
references.pmid: 22985876
references.citation: Pharm Dev Technol. 2014 Feb;19(1):48-54
references.pmid: 23281714
references.citation: Eur J Pharm Sci. 2000 Aug;11(2):157-63
references.pmid: 10915963
references.citation: Curr Med Res Opin. 2010 Dec;26(12):2871-6
references.pmid: 21070097
references.citation: Int J Pharm. 2000 May 10;200(2):243-7
references.pmid: 10867254
references.citation: Arthritis Rheum. 1995 Jan;38(1):5-18
references.pmid: 7818572
references.citation: Physiol Rev. 1999 Oct;79(4):1193-226
references.pmid: 10508233
references.citation: Drugs. 1998 Nov;56(5):783-99
references.pmid: 9829153
references.citation: J Rheumatol. 1984 Aug;11(4):484-7
references.pmid: 6332910
references.citation: Int J Pharm. 2000 Oct 10;207(1-2):31-7
references.pmid: 11036227
references.citation: Sci Pharm. 2013 Jul 14;81(4):1151-66
references.pmid: 24482779
references.citation: Inflammation. 1976 Dec;1(4):415-38
references.pmid: 24194464
references.citation: J Org Chem. 1946 Nov;11(6):798-802
references.pmid: 20282506
references.citation: Pharm Dev Technol. 2013 Jul-Aug;18(4):779-86
references.pmid: 21913880
references.citation: J Pharm Sci. 1994 Nov;83(11):1548-53
references.pmid: 7891272
references.citation: Med J Aust. 1995 Aug 7;163(3):155-8
references.pmid: 7643770
references.citation: BMC Musculoskelet Disord. 2004 Aug 19;5:28
references.pmid: 15317652
references.citation: J Pharm Sci. 2006 Jul;95(7):1405-13
references.pmid: 16729269
references.citation: Int J Pharm. 2005 Apr 11;293(1-2):193-202
references.pmid: 15778057
references.citation: Eur J Clin Pharmacol. 1988;33(6):639-42
references.pmid: 3366168
references.citation: Chem Pharm Bull (Tokyo). 1999 Jun;47(6):749-54
references.pmid: 10399833